Integrative analysis of the PSMA family identifies PSMA6 as an adverse prognostic biomarker promoting bladder cancer cell proliferation
Our findings suggested that PSMA6 might function as an unfavorable prognostic biomarker, fostering BLCA cell proliferation, while also potentially serving as a predictive indicator for the efficacy of immunotherapy in BLCA patients.
Authors
- Bing Shen (ORCID: https://orcid.org/0000-0002-0952-2257)
- Xiangqian Cao
- Huaxing Li
- Yilin Yan
- Zhengnan Huang
- Tengjiao Wang
Institutions
- Tongji University (CN)
- Shanghai Ninth People's Hospital (CN)
- Shanghai Cancer Institute (CN)
- Shanghai Tenth People's Hospital (CN)
- Regenerative Medicine Institute (MX)
- Shanghai Cell Therapy Research Institute (CN)
Publication Details
- Journal
- International Journal of Medical Sciences
- Published
- 2026-02-04
- DOI
- https://doi.org/10.7150/ijms.119034
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00